Skip to main content

WPI 2245 Pill - brown oval, 21mm

Pill with imprint WPI 2245 is Brown, Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Actavis Pharma, Inc.

Mesalamine is used in the treatment of Crohn's Disease, Maintenance; Ulcerative Colitis, Maintenance; Inflammatory Bowel Disease; Ulcerative Colitis, Active; Ulcerative Colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2245

Mesalamine delayed-release 1.2 g WPI 2245
Mesalamine delayed-release 1.2 g WPI 2245

Mesalamine Delayed-Release

WPI 2245
1.2 g
21.00 mm
Prescription only
Drug Class
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
copovidone, silicon dioxide, hypromellose 2910 (6 mPa.s), magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), methacrylic acid - methyl methacrylate copolymer (1:2), ferrosoferric oxide, ferric oxide red, ferric oxide yellow, microcrystalline cellulose, povidone k90, polyethylene glycol 400, polyethylene glycol 3350, polyethylene glycol 8000, propylene glycol, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.